Cargando…
COVID-19: a novel risk factor for perioperative neurocognitive disorders
Autores principales: | Wei, Penghui, Lyu, Wenyuan, Wan, Tiantian, Zheng, Qiang, Tang, Wenxi, Li, Jianjun, Yang, Jian-jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
British Journal of Anaesthesia. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214172/ https://www.ncbi.nlm.nih.gov/pubmed/34266660 http://dx.doi.org/10.1016/j.bja.2021.06.016 |
Ejemplares similares
-
α7 Nicotinic Acetylcholine Receptor May Be a Pharmacological Target for Perioperative Neurocognitive Disorders
por: Wei, Penghui, et al.
Publicado: (2022) -
Putative antiviral effects of propofol in COVID-19
por: Wei, Penghui, et al.
Publicado: (2021) -
Human umbilical cord-derived mesenchymal stem cells ameliorate perioperative neurocognitive disorder by inhibiting inflammatory responses and activating BDNF/TrkB/CREB signaling pathway in aged mice
por: Wei, Penghui, et al.
Publicado: (2023) -
Use of edaravone to decrease perioperative neurocognitive disorders in elderly patients with hip replacement
por: Yuan, Yujing, et al.
Publicado: (2023) -
Case report: perioperative management of caesarean section for a parturient with mitochondrial myopathy
por: Zheng, Qiang, et al.
Publicado: (2017)